» Articles » PMID: 19549021

Prospective Study of Serum 25-hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All-cause Mortality in Older U.S. Adults

Overview
Specialty Geriatrics
Date 2009 Jun 25
PMID 19549021
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate the association between serum 25-hydroxyvitamin D (25(OH)D) levels and mortality in a representative U.S. sample of older adults.

Design: Prospective cohort from the Third National Health and Nutrition Examination Survey (NHANES III) and linked mortality files.

Setting: Noninstitutionalized U.S. civilian population.

Participants: Three thousand four hundred eight NHANES III participants aged 65 and older enrolled from 1988 to 1994 and followed for mortality through 2000.

Measurements: Primary exposure was serum 25(OH)D level at enrollment. Primary and secondary outcomes were all-cause and cardiovascular disease (CVD) mortality, respectively.

Results: During the median 7.3 years of follow-up, there were 1,493 (44%) deaths, including 767 CVD-related deaths. Median 25(OH)D level was 66 nmol/L. Adjusting for demographics, season, and cardiovascular risk factors, baseline 25(OH)D levels were inversely associated with all-cause mortality risk (adjusted hazard ratio (HR)=0.95, 95% confidence interval (CI)=0.92-0.98, per 10 nmol/L 25[OH]D). Compared with subjects with 25(OH)D levels of 100 nmol/L or higher, the adjusted HR for subjects with levels less than 25.0 nmol/L was 1.83 (95% CI=1.14-2.94) and for levels of 25.0 to 49.9 nmol/L was 1.47 (95% CI=1.09-1.97). The association appeared stronger for CVD mortality (adjusted HR=2.36, 95% CI=1.17-4.75, for subjects with 25[OH]D levels<25.0 nmol/L vs those > or =100.0 nmol/L) than for non-CVD mortality (adjusted HR=1.42, 95% CI=0.73-2.79, for subjects with 25[OH]D levels<25.0 nmol/L vs those > or =100.0 nmol/L).

Conclusion: In noninstitutionalized older adults, a group at high risk for all-cause mortality, serum 25(OH)D levels had an independent, inverse association with CVD and all-cause mortality. Randomized controlled trials of vitamin D supplementation in older adults are warranted to determine whether this association is causal and reversible.

Citing Articles

Saturation association between serum 25-hydroxyvitamin D levels and mortality in elderly people with hyperlipidemia: a population-based study from the NHANES (2001-2016).

Pan G, Zhang J, Sun Y, Shi Y, Zhang F Front Endocrinol (Lausanne). 2024; 15:1382419.

PMID: 39415789 PMC: 11479873. DOI: 10.3389/fendo.2024.1382419.


Target Values for 25-Hydroxy and 1,25-Dihydroxy Vitamin D Based on Their Associations with Inflammation and Calcium-Phosphate Metabolism.

Li X, Liu Y, Chen X, Reichetzeder C, Elitok S, Kramer B Nutrients. 2024; 16(16).

PMID: 39203816 PMC: 11357189. DOI: 10.3390/nu16162679.


The causal relationship between 25-hydroxyvitamin D and serum lipids levels: A bidirectional two-sample mendelian randomization study.

Yin T, Zhu X, He Z, Bai H, Shen C, Li R PLoS One. 2024; 19(2):e0287125.

PMID: 38354201 PMC: 10866529. DOI: 10.1371/journal.pone.0287125.


The relationship between the level of vitamin D and ruptured intracranial aneurysms among patients with high sun exposure.

Macedo L, de Castro Tavares R, Torres Braga M, Dos Santos L, Donato G, de Lima Junior F Sci Rep. 2024; 14(1):3555.

PMID: 38347057 PMC: 10861505. DOI: 10.1038/s41598-024-53676-y.


The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension.

Li M Pulm Circ. 2023; 13(4):e12294.

PMID: 37808898 PMC: 10551593. DOI: 10.1002/pul2.12294.